KALLIE GARRETT: Open Payments
NPI 1538777552 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$486 in 20 payments from 9 companies in 2025. Trend: 2023 $1,131 · 2024 $749 · 2025 $486
Food & beverage: $391Education: $95
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 9 | $166 |
| SANOFI-AVENTIS U.S. LLC | 1 | $95 |
| AstraZeneca Pharmaceuticals LP | 3 | $51 |
| ABIOMED | 1 | $42 |
| Electromed, Inc. | 2 | $41 |
| Mallinckrodt Hospital Products Inc. | 1 | $30 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $25 |
| ABBVIE INC. | 1 | $19 |
| Boston Scientific Corporation | 1 | $18 |
Products named: DUPIXENT, SMARTVEST, ACTHAR, AVYCAZ, WATCHMAN FLX, BREZTRI.
Industry payments across OK — which companies pay providers there.
